Growth Metrics

Fennec Pharmaceuticals (FENC) EPS (Weighted Average and Diluted) (QoQ) (2010 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Fennec Pharmaceuticals 281.48 Mn 244.70 Mn 7.67 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -700.00%
Sep 30, 2025 81.82%
Jun 30, 2025 -175.00%
Mar 31, 2025 50.00%
Dec 31, 2024 61.90%
Sep 30, 2024 -5.00%
Jun 30, 2024 -148.78%
Mar 31, 2024 510.00%
Dec 31, 2023 -42.86%
Sep 30, 2023 66.67%
Jun 30, 2023 8.70%
Mar 31, 2023 8.00%
Dec 31, 2022 19.35%
Sep 30, 2022 -63.16%
Jun 30, 2022 -35.71%
Mar 31, 2022 17.65%
Dec 31, 2021 -6.25%
Sep 30, 2021 -6.67%
Jun 30, 2021 16.67%
Mar 31, 2021 -50.00%
Dec 31, 2020 50.00%
Sep 30, 2020 -14.29%
Jun 30, 2020 -10.53%
Sep 30, 2019 62.50%
Jun 30, 2019 -271.43%
Sep 30, 2018 0.00%
Jun 30, 2018 -55.56%
Sep 30, 2017 -36.36%
Jun 30, 2017 -83.33%
Sep 30, 2016 33.33%
Jun 30, 2016 -50.00%
Sep 30, 2015 50.00%
Jun 30, 2015 -300.00%
Mar 31, 2015 -92.86%
Dec 31, 2014 366.67%
Sep 30, 2014 137.50%
Jun 30, 2014 75.76%
Mar 31, 2014 -736.55%
Dec 31, 2013 -561.25%
Sep 30, 2013 83.55%
Jun 30, 2013 -70.57%
Mar 31, 2013 51.85%
Dec 31, 2012 -77.76%
Sep 30, 2012 99.95%
Jun 30, 2012 -45,160.67%
Mar 31, 2012 100.30%
Dec 31, 2011 -95,079.93%
Sep 30, 2011 -70.32%
Jun 30, 2011 -111.99%
Mar 31, 2011 477.99%
Dec 31, 2010 -13.77%
Sep 30, 2010 -126.88%